Cabozantinib for the Management of Metastatic Clear Cell Renal Cell Carcinoma. Journal of Kidney Cancer and VHL, [S. l.], v. 5, n. 4, p. 1–5, 2018. DOI: 10.15586/jkcvhl.2018.109. Disponível em: https://jkcvhl.com/index.php/jkcvhl/article/view/109.. Acesso em: 19 may. 2024.